Barclay Alec 4
4 · T2 Biosystems, Inc. · Filed Feb 23, 2021
Insider Transaction Report
Form 4
Barclay Alec
SVP, Operations
Transactions
- Exercise/Conversion
Common Stock
2021-02-21+10,000→ 72,527 total - Exercise/Conversion
Restricted Stock Units
2021-02-21−10,000→ 10,000 total→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-02-23$2.06/sh−7,280$14,997→ 65,247 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 16,233 shares acquired under the Issuer's employee stock purchase plan on November 15, 2020.
- [F3]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2018.
- [F4]On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.